Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Landin

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Virchows Archiv : an International Journal of Pathology|January 1, 1995
Heterogeneity of islet pathology in two infants with recent onset diabetes mellitusA Lernmark, G Klöppel, D Stenger, et al.
Diabetes/Metabolism Research and Reviews|December 13, 2000
Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical groundsC Törn, M Landin-Olsson, J Ostman, et al.
Diabetologia|September 15, 2004
Conformation-dependent GAD65 autoantibodies in diabetesD Luo, L K Gilliam, C Greenbaum, et al.
Genes and Immunity|January 17, 2014
Variability in the CIITA gene interacts with HLA in multiple sclerosisA Gyllenberg, F Piehl, L Alfredsson, et al.
The American Journal of Cardiology|December 5, 1997
In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantationM Pan, J Suárez de Lezo, A Medina, et al.
Autoimmunity|March 27, 2001
Combinations of beta cell specific autoantibodies at diagnosis of diabetes in young adults reflects different courses of beta cell damageC Törn, M Landin-Olsson, A Lernmark, et al.
Diabetes Care|March 31, 1999
Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetesB Littorin, G Sundkvist, W Hagopian, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 30, 2007
Islet cell autoantibody levels after the diagnosis of young adult diabetic patientsR Jensen, L Gilliam, C Torn, et al.
Diabetes Care|May 26, 2001
Family characteristics and life events before the onset of autoimmune type 1 diabetes in young adults: a nationwide studyB Littorin, G Sundkvist, L Nyström, et al.
The Journal of Clinical Endocrinology and Metabolism|January 3, 2001
Prognostic factors for the course of beta cell function in autoimmune diabetesC Törn, M Landin-Olsson, A Lernmark, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Virchows Archiv : an International Journal of Pathology|January 1, 1995
Heterogeneity of islet pathology in two infants with recent onset diabetes mellitusA Lernmark, G Klöppel, D Stenger, et al.
Diabetes/Metabolism Research and Reviews|December 13, 2000
Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical groundsC Törn, M Landin-Olsson, J Ostman, et al.
Diabetologia|September 15, 2004
Conformation-dependent GAD65 autoantibodies in diabetesD Luo, L K Gilliam, C Greenbaum, et al.
Genes and Immunity|January 17, 2014
Variability in the CIITA gene interacts with HLA in multiple sclerosisA Gyllenberg, F Piehl, L Alfredsson, et al.
The American Journal of Cardiology|December 5, 1997
In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantationM Pan, J Suárez de Lezo, A Medina, et al.
Autoimmunity|March 27, 2001
Combinations of beta cell specific autoantibodies at diagnosis of diabetes in young adults reflects different courses of beta cell damageC Törn, M Landin-Olsson, A Lernmark, et al.
Diabetes Care|March 31, 1999
Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetesB Littorin, G Sundkvist, W Hagopian, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 30, 2007
Islet cell autoantibody levels after the diagnosis of young adult diabetic patientsR Jensen, L Gilliam, C Torn, et al.
Diabetes Care|May 26, 2001
Family characteristics and life events before the onset of autoimmune type 1 diabetes in young adults: a nationwide studyB Littorin, G Sundkvist, L Nyström, et al.
The Journal of Clinical Endocrinology and Metabolism|January 3, 2001
Prognostic factors for the course of beta cell function in autoimmune diabetesC Törn, M Landin-Olsson, A Lernmark, et al.
Pageof 14